FDA Approves Relacorilant for Ovarian, Fallopian, and Peritoneal Cancer

The U.S. Food and Drug Administration approved relacorilant in combination with nab-paclitaxel, offering a new treatment option for adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. The approval represents a major advancement for patients whose disease progressed after one to three prior treatment regimens, including bevacizumab, providing hope for imp...

PSA Test Explained: What It Is, How It Works, and Why It Matters

FDA Approves AVLAYAH, a Milestone in Rare Disease Treatment

Recent News

Telepharmacy Benefits and Trends: Remote Care, Access, and Growth
Mar 26, 2026

Medical Peristaltic Pump Uses, Benefits, and Applications
Mar 26, 2026

Grifols Plans IPO to Boost US Biopharma Business
Mar 26, 2026

Oryon Raises $21M to Propel Parkinson’s Treatment Progress
Mar 26, 2026

Highlights

Canadian Health Technology Partnership Boosts Patient Care Innovation

Cosmetic Surgery: Guide to Procedures & What to Know

Natera Launches Zenith Genomics for Rare Disease in US Healthcare

Pet Diabetes Explained: Causes, Signs & Care Tips

Top 5 News

Canadian Health Technology Partnership Boosts Patient Care Innovation
Mar 26, 2026

Cosmetic Surgery: Guide to Procedures & What to Know
Mar 26, 2026

Natera Launches Zenith Genomics for Rare Disease in US Healthcare
Mar 26, 2026

Pet Diabetes Explained: Causes, Signs & Care Tips
Mar 26, 2026

Celltrion Launches Liquid Remsima IV in Europe to Lead Infliximab Market
Mar 26, 2026

Follow us on

Trending News

Understanding Pulmonary Embolism: Symptoms, Causes, and Treatment
Mar 26, 2026

Vertex’s Povetacicept Shows Breakthrough in Treating Kidney Diseases
Mar 26, 2026

Oncology Nutrition: Foods, Tips, and Cancer Recovery Support
Mar 26, 2026

GAIA and Daiichi Sankyo Europe Partner to Launch Digital Therapeutics
Mar 26, 2026

More News

Living Well with Canine Arthritis: A Guide for Pet Owners
Mar 10, 2026

Chile Achieves WHO Verification for Elimination of Leprosy Disease
Mar 09, 2026

Tele-Intensive Care Unit: Transforming Critical Care
Mar 09, 2026

Medtronic and GE HealthCare Expand Alliance for Technology Innovation
Mar 05, 2026